Sepecifically, we validated that Indirubin, the major bioactive metabolite of Isatidis Folium, exerts its therapeutic effects in sepsis by modulating the EGFR/SRC/PI3K and NF-κB/MAPK signaling pathways. The gene discussed is EGFR; the disease is Sepsis.